Characterization of Nuclear Matrix Protein Alterations Associated with Renal Cell Carcinoma

Urology

Volumn 69, Issue 6, 2007, Pages 1227-1230

  Cannon Jr , Glenn M ^a   Balasudramani, Manimaalha ^a   Getzenberg, Robert H ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; NUCLEAR MATRIX PROTEIN; NUCLEOPORIN; NUCLEOPORIN 54; PROTEIN RCCA 1; PROTEIN RCCA 2; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CARCINOGENESIS; CELL NUCLEUS MATRIX; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; INTRACELLULAR TRANSPORT; KIDNEY CARCINOMA; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PEPTIDE ANALYSIS; PEPTIDE MASS FINGERPRINTING; PRIORITY JOURNAL; PROTEIN DATABASE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEARCH ENGINE; SEQUENCE ANALYSIS;

CARCINOMA, RENAL CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NUCLEAR MATRIX-ASSOCIATED PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 34249985542     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.02.053     Document Type: Article

References (14)

1. American Cancer Society. What Are the Key Statistics for Kidney Cancer (Renal Cell Carcinoma) (2005), American Cancer Society, Atlanta
2. Fawcett D.W. An Atlas of Fine Structure: The Cell, Its Organelles and Inclusions (1966), WB Saunders, Philadelphia
3. Pienta K.J., Partin A.W., and Coffey D.S. Cancer as a disease of DNA organization and dynamic cell structure. Cancer Res 49 (1989) 2525-2532
4. Getzenberg R.H., Pienta K.J., Huang E.Y.W., et al. Identification of nuclear proteins in the cancer and normal rat prostate. Cancer Res 51 (1991) 6514-6520
5. Konety B.R., Nangia A.K., Nguyen T.T., et al. Identification of nuclear matrix protein alterations associated with renal cell carcinoma. J Urol 159 (1998) 1359-1363
6. Fey E.G., and Penman S. Epithelial cytoskeletal framework and nuclear matrix-intermediate filament scaffold: three-dimensional organization and protein composition. J Cell Biol 98 (1984) 1973-1984
7. Ansorge W, Krieger S, Regiert T, et al: NCBI BLAST entry. Direct submission. MIPS, Ingolstaedter Landstr, 2003. Available at: http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&val=31874087. Accessed December 13, 2004.
8. Menaya J, Parrilla R, Ayuso MS: NCBI BLAST entry. Direct submission. Centro de Investigaciones Biologicas, CSIC, 1995. Available at: http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&val=763431. Accessed December 13, 2004.
9. Kau T.R., Way J.C., and Silver P.A. Nuclear transport and cancer: from mechanism to intervention. Nat Rev Cancer 4 (2004) 106-117
10. Gould V.E., Martinez N., Orucevic A., et al. A novel, nuclear-pore associated, widely distributed molecule overexpressed in oncogenesis and development. Am J Pathol 157 (2000) 1605-1613
11. Agudo D., Gomez-Esquer F., Martinez-Arribas F., et al. Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer. Int J Cancer 109 (2004) 717-720
12. Burmeister T., Gokbuget N., Reinhardt R., et al. NUP214-ABL1 in adult T-ALL: the GMALL Study Group experience. Blood 108 (2006) 3556-3559
13. Palmqvist L., Argiropoulos B., Pineault N., et al. The Flt3 receptor tyrosine kinase collaborates with NUP98-HOX fusions in acute myeloid leukemia. Blood 108 (2006) 1030-1036
14. Pannain S., Feldman M., Eiholzer U., et al. Familial dysalbuminemic hyperthyroxinemia in a Swiss family caused by a mutant albumin (R218P) shows an apparent discrepancy between serum concentration and affinity for thyroxine. J Clin Endocrinol Metabol 85 (2000) 2787-2792